Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001591924-13-000001
Filing Date
2013-11-22
Accepted
2013-11-22 09:56:02
Documents
1
Effectiveness Date
2013-11-22
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 9108
  Complete submission text file 0001591924-13-000001.txt   10145
Mailing Address P.O. BOX 110065 RESEARCH TRIANGLE PARK NC 22709
Business Address P.O. BOX 110065 RESEARCH TRIANGLE PARK NC 22709 919-973-1440
Envisia Therapeutics Inc. (Filer) CIK: 0001591924 (see all company filings)

EIN.: 463362788 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-206825 | Film No.: 131237033